These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, Present DH. Gastroenterology; 2004 Sep; 127(3):723-9. PubMed ID: 15362027 [Abstract] [Full Text] [Related]
3. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F, Frigo AC, Fazio V, Marabotto E, Savarino V. Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080 [Abstract] [Full Text] [Related]
4. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Lochs H, Mayer M, Fleig WE, Mortensen PB, Bauer P, Genser D, Petritsch W, Raithel M, Hoffmann R, Gross V, Plauth M, Staun M, Nesje LB. Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454 [Abstract] [Full Text] [Related]
5. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease]. Nos P, Hinojosa J, Aguilera V, Molés JR, Pastor M, Ponce J, Berenguer J. Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650 [Abstract] [Full Text] [Related]
6. Interventions for prevention of post-operative recurrence of Crohn's disease. Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006873. PubMed ID: 19821389 [Abstract] [Full Text] [Related]
7. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR, International AZT-2 Study Group. Gut; 2010 Jun 07; 59(6):752-9. PubMed ID: 20551460 [Abstract] [Full Text] [Related]
8. [Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention]. Karoui S, Kallel L, Boubaker J, Filali A. Tunis Med; 2006 Oct 07; 84(10):595-8. PubMed ID: 17193847 [Abstract] [Full Text] [Related]
9. The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain. Sandborn WJ, Feagan BG. Gastroenterology; 2004 Sep 07; 127(3):990-3. PubMed ID: 15362055 [No Abstract] [Full Text] [Related]
10. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. Papamichael K, Archavlis E, Lariou C, Mantzaris GJ. J Crohns Colitis; 2012 Oct 07; 6(9):924-31. PubMed ID: 22424843 [Abstract] [Full Text] [Related]
11. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Yamamoto T, Umegae S, Matsumoto K. Inflamm Bowel Dis; 2009 Oct 07; 15(10):1460-6. PubMed ID: 19266566 [Abstract] [Full Text] [Related]
12. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study. Armuzzi A, Felice C, Papa A, Marzo M, Pugliese D, Andrisani G, Federico F, De Vitis I, Rapaccini GL, Guidi L. J Crohns Colitis; 2013 Dec 07; 7(12):e623-9. PubMed ID: 23810678 [Abstract] [Full Text] [Related]
13. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, Annese V, Papi C, Viscido A, Cammà C, Corrao G, Latella G. Aliment Pharmacol Ther; 2003 Feb 15; 17(4):517-23. PubMed ID: 12622760 [Abstract] [Full Text] [Related]
14. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M. Ther Drug Monit; 2007 Feb 15; 29(1):1-5. PubMed ID: 17304143 [Abstract] [Full Text] [Related]
15. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Gordon M, Naidoo K, Thomas AG, Akobeng AK. Cochrane Database Syst Rev; 2011 Jan 19; (1):CD008414. PubMed ID: 21249709 [Abstract] [Full Text] [Related]
16. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Hayee BH, Harris AW. Gastroenterology; 2005 Jan 19; 128(1):249; author reply 249-51. PubMed ID: 15633158 [No Abstract] [Full Text] [Related]
17. 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis. Ford AC, Khan KJ, Talley NJ, Moayyedi P. Am J Gastroenterol; 2011 Mar 19; 106(3):413-20. PubMed ID: 20717106 [Abstract] [Full Text] [Related]
18. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease. Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G. Clin Gastroenterol Hepatol; 2003 Mar 19; 1(2):122-8. PubMed ID: 15017504 [Abstract] [Full Text] [Related]
19. The case against routine post-operative therapy for prevention of recurrence in Crohn's disease. Breslin NP, Sutherland LR. Ital J Gastroenterol Hepatol; 1998 Apr 19; 30(2):226-30. PubMed ID: 9675664 [Abstract] [Full Text] [Related]
20. [Crohn disease: prevention and drug therapy]. Gross V, Andus T, Schölmerich J. Chirurg; 1995 Aug 19; 66(8):757-63. PubMed ID: 7587538 [Abstract] [Full Text] [Related] Page: [Next] [New Search]